Involvement of interleukin-6 in atherosclerosis but not in the prevention of fatty streak formation by 17β-estradiol in apolipoprotein E-deficient mice

Atherosclerosis

Volumn 156, Issue 2, 2001, Pages 315-320

  Elhage, R ^a   Clamens, S ^a   Besnard, S ^b   Mallat, Z ^b   Tedgui, A ^b   Arnal, J F ^a   Maret, A ^a   Bayard, F ^a  

^a INSERM   (France)

^b HÔPITAL LARIBOISIÈRE   (France)

Author keywords

Apolipoprotein E deficient mice; Atherosclerosis; Estradiol; Interleukin 6

Indexed keywords

APOLIPOPROTEIN E; CHOLESTEROL; ESTRADIOL; HIGH DENSITY LIPOPROTEIN; INTERLEUKIN 6;

AGE DISTRIBUTION; ANIMAL TISSUE; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; BLOOD VESSEL CALCIFICATION; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DRUG EFFECT; FEMALE; GENE LOCUS; GENOTYPE; HYPERCHOLESTEROLEMIA; LIPOPROTEIN BLOOD LEVEL; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANALYSIS OF VARIANCE; ANIMALS; APOLIPOPROTEINS E; ARTERIOSCLEROSIS; CULTURE TECHNIQUES; DISEASE MODELS, ANIMAL; ESTRADIOL; FEMALE; INTERLEUKIN-6; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; PHOTOMICROGRAPHY; PROBABILITY; SENSITIVITY AND SPECIFICITY; SINUS OF VALSALVA; SPECIES SPECIFICITY;

EID: 0035005368     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(00)00682-1     Document Type: Article

References (32)

1. The biology of interleukin-6
2. IL-6 and APPs: Anti-inflammatory and immunosuppressive mediators
3. IL-6 is an antiinflammatory cytokine required for controlling local or systemic acute inflammatory responses
4. New insights into the cellular, biochemical, and molecular basis of postmenopausal and senile osteoporosis: Roles of IL-6 and gp130
5. Down-modulation of interleukin-6 gene expression by 17 beta-estradiol in the absence of high affinity DNA binding by the estrogen receptor
6. Involvement of CCAAT/enhancer-binding protein and nuclear factor-κβ binding sites in interleukin-6 promoter inhibition by estrogens
7. Regulation of the gp80 and gp130 subunits of the IL-6 receptor by sex steroids in the murine bone marrow
8. 17 beta-estradiol inhibits expression of human interleukin-6 promoter-reporter constructs by a receptor-dependent mechanism
9. Interleukin-6 deficient mice are protected from bone loss caused by estrogen depletion
10. Increased osteoclast development after estrogen loss: Mediation by interleukin-6
11. 17β-estradiol inhibits interleukin-6 production by bone marrow-derived stromal cells and osteoblasts in vitro: A potential mechanism for the antiosteoporotic effect of estrogens
12. Increased production of tumor necrosis factor and interleukin-6 by arterial wall of aged rats
13. Localization of T lymphocytes and macrophages expressing IL-1, IL-12 receptor, IL-6 and TNF in human aortic intima: Role of cell mediated immunity in human atherogenesis
14. Expression of interleukin-6 in atherosclerotic lesions of male ApoE- knockout mice: Inhibition by 17beta-estradiol
15. Interleukin 6 transcripts are expressed in atherosclerotic lesions of genetically hyperlipidemic rabbits
16. Interleukin 6 gene transcripts are expressed in human atherosclerotic lesions
17. Increased apolipoprotein E and c-fms gene expression without elevated interleukin 1 or 6 mRNA levels indicates selective activation of macrophage functions in advanced human atheroma
18. Estrogen reduces atherosclerotic lesion development in apolipoprotein E-deficient mice
19. 17 beta-estradiol prevents fatty streak formation in apolipoprotein E-deficient mice
20. Impaired immune and acute-phase responses in interleukin-6-deficient mice
21. Pathology of atheromatous lesions in inbred and genetically engineered mice. Genetic determination of arterial calcification
22. Serum dehydroepiandrosterone (DHEA) and DHEA sulfate are negatively correlated with serum interleukin-6 (IL-6), and DHEA inhibits IL-6 secretion from mononuclear cells in man in vitro: Possible link between endocrinosenescence and immunosenescence
23. Comparative analysis of cytokine induction in human vascular endothelial and smooth muscle cells
24. Proliferating or interleukin 1-activated human vascular smooth muscle cells secrete copious interleukin 6
25. Regulation of interleukin-11 protein and mRNA expression in neonatal and adult fibroblasts and endothelial cells
26. Oncostatin M is a mitogen for rabbit vascular smooth muscle cells
27. Human leukemia inhibitory factor inhibits development of experimental atherosclerosis
28. Interleukin-6 exacerbates early atherosclerosis in mice
29. Expression of the IL-6 gene is not regulated by estrogen in smooth muscle cells
30. Risk of thrombosis in human athersclerotic plaques: Role of extracellular lipid, macrophage, and smooth muscle cell concent
31. Apoptosis of vascular smooth-muscle cells inducted by in vitro stimulation with interferon-gamma, tumor necrosis factor-alpha, and interleukin-1-beta
32. Athersclerotic plaque rupture: Emerging insights and opportunities